LISA CRAFT: Open Payments
NPI 1699883603 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$941 in 49 payments from 8 companies in 2025. Trend: 2023 $44 · 2024 $156 · 2025 $941
Food & beverage: $941
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 24 | $362 |
| ViiV Healthcare Company | 13 | $306 |
| Merck Sharp & Dohme LLC | 4 | $94 |
| ARGENX US, INC. | 2 | $49 |
| Axsome Therapeutics, Inc. | 2 | $45 |
| EMD Serono, Inc. | 1 | $34 |
| PFIZER INC. | 2 | $31 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: DOVATO, CABENUVA, PIFELTRO, APRETUDE, VYVGART HYTRULO, Biktarvy, Symbravo, PREVNAR 20.
Industry payments across LA — which companies pay providers there.
